Literature DB >> 28194491

[Merkel cell carcinoma: cutaneous manifestation of a highly malignant pre-/pro-B cell neoplasia? : Novel concept about the cellular origin of Merkel cell carcinoma].

C M Sauer1,2, E Chteinberg1, D Rennspiess1, A K Kurz2, A Zur Hausen3.   

Abstract

Merkel cell carcinoma (MCC) is a relatively rare but highly malignant non-melanoma skin cancer of the elderly and immunosuppressed patients. The discovery of the Merkel cell polyomavirus (MCPyV) in 2008 significantly impacted the understanding of the etiopathogenesis of MCC. MCPyV is clonally integrated into the MCC genome and approximately 80% of MCC are MCPyV-positive. Recent results of clinical trials using blockade of the PD-1 immune modulatory pathway are promising for the future treatment of MCC. Despite this major progress of the past few years, the cellular origin of MCC still remains obscure. Based on histomorphology, gene expression profiling, and molecular analyses, we have recently hypothesized that MCC originates from pre‑/pro-B cells. Here we review putative cells of MCC, including Merkel cells, (epi‑)dermal stem cells, and pro‑/pre-B cells. In the present work, the focus is on the concept of pre‑/pro-B cells as the cellular origin of MCC, which might also impact the understanding of other human small cell malignancies of unknown cellular origin, such as small cell carcinomas of the lung and other anatomical locations. In addition, this concept might pave the way for novel treatment options, especially for advanced MCC.

Entities:  

Keywords:  B cells; Cellular origin; Histology; Polyomavirus; Skin neoplasms

Mesh:

Year:  2017        PMID: 28194491     DOI: 10.1007/s00105-017-3945-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  40 in total

1.  Immunoglobulin expressions are only associated with MCPyV-positive Merkel cell carcinomas but not with MCPyV-negative ones: comparison of prognosis.

Authors:  Ichiro Murakami; Katsuyoshi Takata; Michiko Matsushita; Daisuke Nonaka; Takeshi Iwasaki; Satoshi Kuwamoto; Masako Kato; Takashi Mohri; Keiko Nagata; Yukisato Kitamura; Tadashi Yoshino; Kazuhiko Hayashi
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394

2.  Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma.

Authors:  Ryan C Fields; Klaus J Busam; Joanne F Chou; Katherine S Panageas; Melissa P Pulitzer; Peter J Allen; Dennis H Kraus; Mary S Brady; Daniel G Coit
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

3.  CD56 staining in Merkel cell carcinoma and natural killer-cell lymphoma: magic bullet, diagnostic pitfall, or both?

Authors:  Jennifer M McNiff; Shawn E Cowper; Rossitza Lazova; Antonio Subtil; Earl J Glusac
Journal:  J Cutan Pathol       Date:  2005-09       Impact factor: 1.587

4.  MC polyomavirus is frequently present in Merkel cell carcinoma of European patients.

Authors:  Jürgen C Becker; Roland Houben; Selma Ugurel; Uwe Trefzer; Claudia Pföhler; David Schrama
Journal:  J Invest Dermatol       Date:  2008-07-17       Impact factor: 8.551

5.  Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.

Authors:  Roland Houben; Masahiro Shuda; Rita Weinkam; David Schrama; Huichen Feng; Yuan Chang; Patrick S Moore; Jürgen C Becker
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

6.  Proliferative Merkel cells were not detected in human skin.

Authors:  I Moll; W Zieger; M Schmelz
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

7.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.

Authors:  Kelly G Paulson; Jayasri G Iyer; Andrew R Tegeder; Renee Thibodeau; Janell Schelter; Shinichi Koba; David Schrama; William T Simonson; Bianca D Lemos; David R Byrd; David M Koelle; Denise A Galloway; J Helen Leonard; Margaret M Madeleine; Zsolt B Argenyi; Mary L Disis; Juergen C Becker; Michele A Cleary; Paul Nghiem
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

8.  Cutaneous neuroendocrine (Merkel cell) carcinoma: an immunophenotypic, clinicopathologic, and flow cytometric study.

Authors:  D Visscher; P H Cooper; R J Zarbo; J D Crissman
Journal:  Mod Pathol       Date:  1989-07       Impact factor: 7.842

9.  Merkel cell carcinoma dependence on bcl-2 family members for survival.

Authors:  Monique E Verhaegen; Doris Mangelberger; Jack W Weick; Tracy D Vozheiko; Paul W Harms; Kevin T Nash; Elsa Quintana; Paul Baciu; Timothy M Johnson; Christopher K Bichakjian; Andrzej A Dlugosz
Journal:  J Invest Dermatol       Date:  2014-03-10       Impact factor: 8.551

Review 10.  Pax5: the guardian of B cell identity and function.

Authors:  César Cobaleda; Alexandra Schebesta; Alessio Delogu; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2007-05       Impact factor: 25.606

View more
  2 in total

Review 1.  Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.

Authors:  Jürgen C Becker; Andreas Stang; Axel Zur Hausen; Nicole Fischer; James A DeCaprio; Richard W Tothill; Rikke Lyngaa; Ulla Kring Hansen; Cathrin Ritter; Paul Nghiem; Christopher K Bichakjian; Selma Ugurel; David Schrama
Journal:  Cancer Immunol Immunother       Date:  2017-11-30       Impact factor: 6.968

Review 2.  [Merkel-cell carcinoma].

Authors:  I Moll
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.